Emergent BioSolutions Reports FDA Advisory Committees’

Emergent BioSolutions Reports FDA Advisory Committees’

If approved by the FDA, NARCAN Nasal Spray will be the first 4 mg naloxone nasal spray switched from prescription status to over-the-counter use ......

menu
menu